Login / Signup

Severe colitis in patients with melanoma treated with BRAF/MEK inhibitors.

Franck CarbonnelEmilie RoutierThierry LazureCharlotte MussiniChristophe BellangerCarine MerklenBakhtiar BejouAnthony BuissonAurélien AmiotAntoine MeyerCatherine DongCaroline Robert
Published in: Alimentary pharmacology & therapeutics (2022)
BRAF/MEK inhibitors can induce severe colitis characterised by ulcerations of the right colon.
Keyphrases
  • early onset
  • pi k akt
  • metastatic colorectal cancer
  • ulcerative colitis
  • wild type
  • signaling pathway
  • newly diagnosed